PATENT CLAIM ANALYSIS

Application Number: 16302158
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["514", "210180"]

Abstract:
The present invention provides compounds of Formula (I): as defined in the specification and compositions comprising any of such novel compounds. These compounds are endothelial lipase inhibitors which may be used as medicament.

Claim (Index 6):
The compound according to  claim 1 , wherein\n R 6  is not present or R 6  is OH, halogen, C 1-6  alkyl, C 1-4  alkoxy, C 1-4  haloalkyl, NH 2 , NHR g , and \u2014CONR h R i ; R g  is C 1-4  alkyl, CO 2 R m , CONHR p , or CONR n R p ; R h  and R i  are independently hydrogen, C 1-4  alkyl, C 1-4  alkoxy, C 1-4  haloalkyl, C 1-4  haloalkoxy; or alternatively, R h  and R i , taken together with the atoms to which they are attached, form a 5- or 6-membered azacyclyl comprising one or more carbon atoms and 1 to 4 heteroatoms selected from N, NR a , O, and S(O) Z , wherein the azacyclyl is substituted with 0, 1, or 2 R 9 ; and R m , R n , and R p  are independently C 1-4  alkyl, C 1-4  alkoxy, C 1-4  haloalkyl, or C 1-4  haloalkoxy.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 98.0
- Lexical Diversity: 1.15152
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13936311', '13944921', '14427105', '14346745', '14390152']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7445624180693712
- 35 USC 102 Novelty (BERT): 0.5207587257206232
- Combined Prediction Score: 0.7221820488344964
- Mean Citation Score: 302.8511640000001
- Max Citation Score: 311.87286
- Similarity Product: 245.93755516098616

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test